| Drug Name: | Ursodeoxycholic acid (128-13-2) |
|---|---|
| PubChem ID: | 31401 |
| SMILES: | C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C |
| InchiKey: | RUDATBOHQWOJDD-UZVSRGJWSA-N |
| Therapeutic Category: | Cholagogues and Choleretics, Gastrointestinal Agents |
| Molecular Weight (dalton) | : | 392.58 |
| LogP | : | 4.4779 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 3 |
| Total Polar Surface Area | : | 77.76 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Dapsone (80-08-0) | Effectiveness Of Dapsone In The Treatment Of Dermatitis Herpetiformis Is Reduced | Antagonistic | Not understood | A single case suggests that the effectiveness of dapsone in the treatment of dermatitis herpetiformis may be reduced by ursodeoxycholic acid |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category